Cydex Pharmaceuticals Inc
Founded 1987 · 1 known investors
Find your way into Cydex Pharmaceuticals Inc
Captisol is a pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), a derivatized beta cyclodextrin used to solubilize and stabilize difficult-to-deliver molecules across routes such as parenteral, oral, ophthalmic, nasal, and inhalation. Made by CyDex Pharmaceuticals (a Ligand company), it is used in approved therapeutics including remdesivir and carfilzomib, and is also explored for consumer health, supplements, and personal care products.
Investors · 1
Competitors · 2
by search overlap
Celldex Therapeutics, Inc.8 shared keywordsCelldex is a biotechnology company developing therapeutics across therapeutic areas including immunology and inflammation. The page shown is a board director biography rather than a company overview.
1Mg7 shared keywordsThis is a product listing page on an online pharmacy for Tugain Twins 5 Solution, a topical minoxidil-based medicine sold to treat hair loss and promote hair regrowth. The page provides usage instructions, benefits, side effects, and purchase/return details rather than describing a company.
Companies competing with Cydex Pharmaceuticals Inc for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cydex Pharmaceuticals Inc do?
- Captisol is a pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), a derivatized beta cyclodextrin used to solubilize and stabilize difficult-to-deliver molecules across routes such as parenteral, oral, ophthalmic, nasal, and inhalation. Made by CyDex Pharmaceuticals (a Ligand company), it is used in approved therapeutics including remdesivir and carfilzomib, and is also explored for consumer health, supplements, and personal care products.
- Who are Cydex Pharmaceuticals Inc's investors?
- Cydex Pharmaceuticals Inc's investors include RiverVest Venture Partners.